Airway Obstruction: Clinical Trials

24 trials for Airway Obstruction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 3 terminated, 3 unknown, 2 recruiting. 24 Phase 2, 5 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 224Completed 14, Terminated 3, Unknown 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1
Phase 15Completed 4, Terminated 1
Phase 31Withdrawn 1

Follow Airway Obstruction: new trials by email Literature Review of Airway Obstruction trials Research Report on Airway Obstruction

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Investigate the Efficacy and Safety of Apomivir®
Apomivir®, Placebo - Influenza
Phase 2Not yet recruitingFar East Bio-Tec Co., Ltd1962026-05-312025-05-14
A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults
Oxymetazoline HCl 0.05% nasal gel, Placebo nasal gel - Nasal Congestion, Nasal Obstruction
Phase 2CompletedBayer1202026-04-202026-06-08
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
Oxymetazoline + Triamcinolone - Nasal Obstruction, Chronic Rhinitis
Phase 2TerminatedWashington University School of Medicine32025-11-102026-03-23
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
PF-07275315, Placebo - Asthma
Phase 2RecruitingPfizer2522025-05-202026-11-06
Nasal Obstruction With Oxymetazoline and Corticosteroids
Oxymetazoline Nasal Spray, Budesonide nasal spray - Nasal Obstruction
Phase 2RecruitingWashington University School of Medicine802024-10-152025-09-11
Biological Effects of Quercetin in COPD Phase II
Quercetin 1000 mg, Quercetin 500 MG, Placebo - Chronic Obstructive Pulmonary Disease, Emphysema
Phase 2UnknownTemple University302023-11-012024-04-08
Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
CPM, Placebo - Allergic Rhinitis, Nasal Congestion
Phase 2 / Phase 3WithdrawnLarkin Community Hospital2019-07-302023-10-16
Intranasal Capsaicin Treatment for Non-Allergic Irritant Rhinitis
Capsaicin, Placebo - Nonallergic Irritant Rhinitis
Phase 2CompletedThe University of Texas Health Science Center, Houston222014-10-012020-08-17
Market Potential of Carbon Dioxide Nasal Spray
Carbon Dioxide - Nasal Congestion
Phase 2CompletedGlaxoSmithKline1472013-11-012015-04-30
Effectiveness of Continuous Negative External Pressure in Preventing Upper Airway Impairment During Routine Colonoscopy
Airway Management System (AMS) - Airway Obstruction, Apnea
Phase 1 / Phase 2Completed5i Sciences, Inc.542013-03-012014-08-06
Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis
S-555739 Dose 1, S-555739 Dose 2, Cetirizine HCl Dose 1 - Seasonal Allergic Rhinitis
Phase 2CompletedShionogi7792012-07-012018-04-27
Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash
Calcium Glycerophosphate Nasal Spray Wash - Allergic Rhinitis
Phase 1 / Phase 2CompletedDrexel University172012-05-012015-05-25
A Pivotal Study to Assess the Effectiveness of Nasal Dilator (Breathe Right Nasal Strips)
Breathe Right Tan (small/medium) nasal strips, Placebo nasal strip - Congestion, Nasal
Phase 2CompletedGlaxoSmithKline1302010-11-042018-09-25
A Pivotal Subjective Sleep Study of a Nasal Dilator (Breathe Right Tan)
Breathe Right Tan (small/medium) nasal strips, Placebo nasal strip - Congestion, Nasal
Phase 2CompletedGlaxoSmithKline1402010-10-252018-09-25
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)
Bilastine - Allergic Rhinoconjunctivitis, Chronic Urticaria
Phase 1 / Phase 2CompletedFaes Farma, S.A.362010-01-012012-09-26
Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma
sitaxentan, placebo - Effect of Sitaxsentan on Airway Remodeling in Severe Asthma
Phase 2TerminatedInstitut National de la Santé Et de la Recherche Médicale, France172009-11-012012-05-10
Exploratory Subjective Sleep Study of a Prototype Nasal Dilator
Prototype Nasal Dilator, Marketed Nasal Strip, Placebo Nasal Strip - Sleep Disorders, Congestion, Nasal
Phase 2CompletedGlaxoSmithKline612009-10-012018-04-09
To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.
Prototype nasal dilator strip, No strip - Sleep Disordered Breathing, Congestion, Nasal
Phase 2CompletedGlaxoSmithKline912009-09-252019-07-26
Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199
AZD3199, Formoterol, Placebo - Asthma, Airway Obstruction
Phase 2CompletedAstraZeneca372008-08-012014-05-19
Study of Polyester Implants for the Treatment of External Nasal Valve Collapse (NVC)
Polyester Implants - Nasal Alar Collapse, Bilateral
Phase 1 / Phase 2TerminatedMedtronic Xomed, Inc.452008-04-012012-01-06

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Nasal Obstruction (16)  ·  Asthma (3)  ·  Rhinitis, Allergic (3)  ·  Sneezing (3)  ·  Dyspnea (2)  ·  Rhinitis (2)  ·  Rhinitis, Allergic, Seasonal (2)  ·  Rhinorrhea (2)  ·  Sleep Apnea Syndromes (2)  ·  Airway Remodeling (1)  ·  Apnea (1)  ·  Chronic Urticaria (1)  ·  Cough (1)  ·  Emphysema (1)

Broader conditions

Respiration Disorders (24)  ·  Respiratory Insufficiency (24)  ·  Respiratory Tract Diseases (23)  ·  Otorhinolaryngologic Diseases (17)  ·  Nose Diseases (16)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Signs and Symptoms (9)  ·  Hypersensitivity, Immediate (7)  ·  Immune System Diseases (7)  ·  Signs and Symptoms, Respiratory (7)  ·  Hypersensitivity (6)  ·  Respiratory Hypersensitivity (6)  ·  Lung Diseases, Obstructive (4)  ·  Bronchial Diseases (3)

Interventions

Oxymetazoline (3)  ·  Culture Media (2)  ·  Dexamethasone (2)  ·  AZD-3199 (1)  ·  Budesonide (1)  ·  Capsaicin (1)  ·  Carbon Dioxide (1)  ·  Chlorpheniramine (1)  ·  Ethanol (1)  ·  Formoterol Fumarate (1)  ·  Quercetin (1)  ·  Sodium Chloride (1)  ·  Triamcinolone (1)  ·  bilastine (1)  ·  heliox (1)

Sponsors

GlaxoSmithKline (5)  ·  Mackay Memorial Hospital (2)  ·  Washington University School of Medicine (2)  ·  5i Sciences, Inc. (1)  ·  AstraZeneca (1)  ·  Bayer (1)  ·  Drexel University (1)  ·  Faes Farma, S.A. (1)  ·  Far East Bio-Tec Co., Ltd (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  Larkin Community Hospital (1)  ·  Medtronic Xomed, Inc. (1)  ·  Pfizer (1)  ·  Shionogi (1)  ·  Temple University (1)

Countries

United States (14)  ·  Taiwan (4)  ·  Australia (2)  ·  Germany (2)  ·  Sweden (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Hungary (1)  ·  Italy (1)

Top investigators

Chao-Hsien Lee, MD (2)  ·  Amber U Luong, MD, PhD (1)  ·  Edward M. Weaver, MD, MPH (1)  ·  Edward S Schulman, MD (1)  ·  Gunilla Hedlin, Prof. Dr. (1)  ·  Hubert Trubel, MD (1)  ·  Lennart Nordvall, Prof. Dr (1)  ·  Liang-Wen Hang, MD (1)  ·  Marcos A Sanchez-Gonzalez (1)  ·  Nathaniel Marchetti (1)  ·  Noel E Cranswick, Prof. Dr. (1)  ·  Nyssa F Farrell, MD (1)  ·  Nyssa Farrell, MD (1)

Results publications

PMID 31209698, PMID 15725047, PMID 16424722, PMID 16540947, PMID 17605780, PMID 20920189, PMID 22465313, PMID 23907810, PMID 27110692, PMID 27178892, PMID 29800001, PMID 29975735, PMID 30154874, PMID 30850876, PMID 31119695, PMID 32071149, PMID 8874303

NIH funding

2009 (1), R01HL084139 (1), R33AT009991 (1)